NCT04088916View on ClinicalTrials.gov

Proviral DNA as a Target for HIV-1 Resistance Analysis

UnknownOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

September 8, 2019

Study Completion Date

December 31, 2022

Conditions

HIV/AIDSHIV InfectionsHIV SeropositivityViral Infection

Trial Locations (2)

Unknown

RECRUITING

Immunology, HIV and Allergy Section, Santiago

RECRUITING

Molecular Medicine Laboratory, Santiago

Sponsors

Collaborators (1)

ViiV Healthcare

All Listed Sponsors

collaborator

ViiV Healthcare

INDUSTRY

lead

University of Chile

OTHER